LXRX NASDAQ
Lexicon Pharmaceuticals, Inc.
1W: -11.6%
1M: +15.8%
3M: +61.4%
YTD: +77.5%
1Y: +330.0%
3Y: -10.1%
5Y: -61.3%
$2.20
+0.07 (+3.51%)
Weekly Expected Move ±14.6%
$2
$2
$2
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$2.7M
Congress—
ETF Holdings—
Key Statistics
Market Cap$946.1M
52W Range0.52-2.53
Volume1,624,447
Avg Volume2,703,855
Beta0.97
Dividend—
Analyst Ratings
Company Info
CEOMichael S. Exton
Employees103
SectorHealthcare
IndustryBiotechnology
IPO Date2000-04-07
Websitelexpharma.com
2445 Technology Forest Boulevard
The Woodlands, TX 77381
US
The Woodlands, TX 77381
US
281 863 3000
About Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.
Latest News
Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
12 Health Care Stocks Moving In Monday's Intraday Session
Lexicon anticipates SONATA-HCM enrollment completion by mid-2026 while highlighting $100m Hercules debt facility
Lexicon Pharmaceuticals (LXRX) Reports Break-Even Earnings for Q1
Lexicon Pharmaceuticals reports Q1 results
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Amouyal Philippe | A-Award | 43,478 | $1.61 | 2026-05-01 |
| Amouyal Philippe | A-Award | 35,714 | — | 2026-05-01 |
| SOBECKI CHRISTOPHER | A-Award | 43,478 | $1.61 | 2026-05-01 |
| SOBECKI CHRISTOPHER | A-Award | 35,714 | — | 2026-05-01 |
| BARKER SAM L | A-Award | 43,478 | $1.61 | 2026-05-01 |